0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hemostatic and Tissue Sealing Agents Market Research Report 2026
Published Date: 2026-02-26
|
Report Code: QYRE-Auto-30O8758
Home | Market Reports | Health| Medical Devices & Equipment
Global Hemostatic and Tissue Sealing Agents Market Outlook 2022
BUY CHAPTERS

Global Hemostatic and Tissue Sealing Agents Market Research Report 2026

Code: QYRE-Auto-30O8758
Report
2026-02-26
Pages:137
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hemostatic and Tissue Sealing Agents Market Size

The global Hemostatic and Tissue Sealing Agents market was valued at US$ 3051 million in 2025 and is anticipated to reach US$ 3742 million by 2032, at a CAGR of 3.0% from 2026 to 2032.

Hemostatic and Tissue Sealing Agents Market

Hemostatic and Tissue Sealing Agents Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Hemostatic and Tissue Sealing Agents competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Hemostasis is defined as "the blocking of bleeding or bleeding through blood vessels or other parts of the body".Hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually lead to surgery for patients, which in turn promotes the development of the hemostasis and tissue sealant industries.
Global Hemostatic and Tissue Sealing Agents key players include J&J, Baxter, C R Bard, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share about 60%, followed by China, and Europe, both have a share about 30 percent.
In terms of product, Hemostatic is the largest segment, with a share about 75%. And in terms of application, the largest application is General Surgery, followed by Minimally Invasive Surgery, etc.
This report delivers a comprehensive overview of the global Hemostatic and Tissue Sealing Agents market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Hemostatic and Tissue Sealing Agents. The Hemostatic and Tissue Sealing Agents market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Hemostatic and Tissue Sealing Agents market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Hemostatic and Tissue Sealing Agents manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Hemostatic and Tissue Sealing Agents Market Report

Report Metric Details
Report Name Hemostatic and Tissue Sealing Agents Market
Accounted market size in 2025 US$ 3051 million
Forecasted market size in 2032 US$ 3742 million
CAGR 3.0%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Hemostatic
  • Sealant Gum
by Application
  • Minimally Invasive Surgery
  • General Surgery
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company J&J, Baxter, C R Bard, B Braun, Integra Life Sciences, Advance Medical Solution, CSL Behring, CryoLife, Zimmer Biomet, Pfizer, Medtronic, Smith & Nephew, Cohera Medical, Shanghai Haohai Biological Technology Co. Ltd., Shandong Saikesaisi Biotechnology Co., Ltd, Chang ShaHai Run biological technology Co, LTD
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Hemostatic and Tissue Sealing Agents manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Hemostatic and Tissue Sealing Agents sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Hemostatic and Tissue Sealing Agents Market growing?

Ans: The Hemostatic and Tissue Sealing Agents Market witnessing a CAGR of 3.0% during the forecast period 2026-2032.

What is the Hemostatic and Tissue Sealing Agents Market size in 2032?

Ans: The Hemostatic and Tissue Sealing Agents Market size in 2032 will be US$ 3742 million.

What is the market share of major companies in Hemostatic and Tissue Sealing Agents Market?

Ans: Global top three manufacturers hold a share over 45%.

What is the Hemostatic and Tissue Sealing Agents Market share by type?

Ans: In terms of product, Hemostatic is the largest segment, with a share about 75%.

Who are the main players in the Hemostatic and Tissue Sealing Agents Market report?

Ans: The main players in the Hemostatic and Tissue Sealing Agents Market are J&J, Baxter, C R Bard, B Braun, Integra Life Sciences, Advance Medical Solution, CSL Behring, CryoLife, Zimmer Biomet, Pfizer, Medtronic, Smith & Nephew, Cohera Medical, Shanghai Haohai Biological Technology Co. Ltd., Shandong Saikesaisi Biotechnology Co., Ltd, Chang ShaHai Run biological technology Co, LTD

What are the Application segmentation covered in the Hemostatic and Tissue Sealing Agents Market report?

Ans: The Applications covered in the Hemostatic and Tissue Sealing Agents Market report are Minimally Invasive Surgery, General Surgery, Other

What are the Type segmentation covered in the Hemostatic and Tissue Sealing Agents Market report?

Ans: The Types covered in the Hemostatic and Tissue Sealing Agents Market report are Hemostatic, Sealant Gum

1 Hemostatic and Tissue Sealing Agents Market Overview
1.1 Product Definition
1.2 Hemostatic and Tissue Sealing Agents by Type
1.2.1 Global Hemostatic and Tissue Sealing Agents Market Value by Type: 2025 vs 2032
1.2.2 Hemostatic
1.2.3 Sealant Gum
1.3 Hemostatic and Tissue Sealing Agents by Application
1.3.1 Global Hemostatic and Tissue Sealing Agents Market Value by Application: 2025 vs 2032
1.3.2 Minimally Invasive Surgery
1.3.3 General Surgery
1.3.4 Other
1.4 Global Hemostatic and Tissue Sealing Agents Market Size Estimates and Forecasts
1.4.1 Global Hemostatic and Tissue Sealing Agents Revenue 2021–2032
1.4.2 Global Hemostatic and Tissue Sealing Agents Sales 2021–2032
1.4.3 Global Hemostatic and Tissue Sealing Agents Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Hemostatic and Tissue Sealing Agents Market Competition by Manufacturers
2.1 Global Hemostatic and Tissue Sealing Agents Sales Market Share by Manufacturers (2021–2026)
2.2 Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Hemostatic and Tissue Sealing Agents Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Hemostatic and Tissue Sealing Agents, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Hemostatic and Tissue Sealing Agents, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Hemostatic and Tissue Sealing Agents, Product Types and Applications
2.7 Global Key Manufacturers of Hemostatic and Tissue Sealing Agents, Date of Entry into the Industry
2.8 Global Hemostatic and Tissue Sealing Agents Market Competitive Situation and Trends
2.8.1 Global Hemostatic and Tissue Sealing Agents Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Hemostatic and Tissue Sealing Agents Players Market Share by Revenue
2.8.3 Global Hemostatic and Tissue Sealing Agents Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hemostatic and Tissue Sealing Agents Market Scenario by Region
3.1 Global Hemostatic and Tissue Sealing Agents Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Hemostatic and Tissue Sealing Agents Sales by Region: 2021–2032
3.2.1 Global Hemostatic and Tissue Sealing Agents Sales by Region: 2021–2026
3.2.2 Global Hemostatic and Tissue Sealing Agents Sales by Region: 2027–2032
3.3 Global Hemostatic and Tissue Sealing Agents Revenue by Region: 2021–2032
3.3.1 Global Hemostatic and Tissue Sealing Agents Revenue by Region: 2021–2026
3.3.2 Global Hemostatic and Tissue Sealing Agents Revenue by Region: 2027–2032
3.4 North America Hemostatic and Tissue Sealing Agents Market Facts & Figures by Country
3.4.1 North America Hemostatic and Tissue Sealing Agents Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Hemostatic and Tissue Sealing Agents Sales by Country (2021–2032)
3.4.3 North America Hemostatic and Tissue Sealing Agents Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemostatic and Tissue Sealing Agents Market Facts & Figures by Country
3.5.1 Europe Hemostatic and Tissue Sealing Agents Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Hemostatic and Tissue Sealing Agents Sales by Country (2021–2032)
3.5.3 Europe Hemostatic and Tissue Sealing Agents Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemostatic and Tissue Sealing Agents Market Facts & Figures by Region
3.6.1 Asia Pacific Hemostatic and Tissue Sealing Agents Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Hemostatic and Tissue Sealing Agents Sales by Region (2021–2032)
3.6.3 Asia Pacific Hemostatic and Tissue Sealing Agents Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hemostatic and Tissue Sealing Agents Market Facts & Figures by Country
3.7.1 Latin America Hemostatic and Tissue Sealing Agents Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Hemostatic and Tissue Sealing Agents Sales by Country (2021–2032)
3.7.3 Latin America Hemostatic and Tissue Sealing Agents Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemostatic and Tissue Sealing Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemostatic and Tissue Sealing Agents Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Hemostatic and Tissue Sealing Agents Sales by Country (2021–2032)
3.8.3 Middle East and Africa Hemostatic and Tissue Sealing Agents Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hemostatic and Tissue Sealing Agents Sales by Type (2021–2032)
4.1.1 Global Hemostatic and Tissue Sealing Agents Sales by Type (2021–2026)
4.1.2 Global Hemostatic and Tissue Sealing Agents Sales by Type (2027–2032)
4.1.3 Global Hemostatic and Tissue Sealing Agents Sales Market Share by Type (2021–2032)
4.2 Global Hemostatic and Tissue Sealing Agents Revenue by Type (2021–2032)
4.2.1 Global Hemostatic and Tissue Sealing Agents Revenue by Type (2021–2026)
4.2.2 Global Hemostatic and Tissue Sealing Agents Revenue by Type (2027–2032)
4.2.3 Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Type (2021–2032)
4.3 Global Hemostatic and Tissue Sealing Agents Price by Type (2021–2032)
5 Segment by Application
5.1 Global Hemostatic and Tissue Sealing Agents Sales by Application (2021–2032)
5.1.1 Global Hemostatic and Tissue Sealing Agents Sales by Application (2021–2026)
5.1.2 Global Hemostatic and Tissue Sealing Agents Sales by Application (2027–2032)
5.1.3 Global Hemostatic and Tissue Sealing Agents Sales Market Share by Application (2021–2032)
5.2 Global Hemostatic and Tissue Sealing Agents Revenue by Application (2021–2032)
5.2.1 Global Hemostatic and Tissue Sealing Agents Revenue by Application (2021–2026)
5.2.2 Global Hemostatic and Tissue Sealing Agents Revenue by Application (2027–2032)
5.2.3 Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Application (2021–2032)
5.3 Global Hemostatic and Tissue Sealing Agents Price by Application (2021–2032)
6 Key Companies Profiled
6.1 J&J
6.1.1 J&J Company Information
6.1.2 J&J Description and Business Overview
6.1.3 J&J Hemostatic and Tissue Sealing Agents Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 J&J Hemostatic and Tissue Sealing Agents Product Portfolio
6.1.5 J&J Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Company Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Hemostatic and Tissue Sealing Agents Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Baxter Hemostatic and Tissue Sealing Agents Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 C R Bard
6.3.1 C R Bard Company Information
6.3.2 C R Bard Description and Business Overview
6.3.3 C R Bard Hemostatic and Tissue Sealing Agents Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 C R Bard Hemostatic and Tissue Sealing Agents Product Portfolio
6.3.5 C R Bard Recent Developments/Updates
6.4 B Braun
6.4.1 B Braun Company Information
6.4.2 B Braun Description and Business Overview
6.4.3 B Braun Hemostatic and Tissue Sealing Agents Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 B Braun Hemostatic and Tissue Sealing Agents Product Portfolio
6.4.5 B Braun Recent Developments/Updates
6.5 Integra Life Sciences
6.5.1 Integra Life Sciences Company Information
6.5.2 Integra Life Sciences Description and Business Overview
6.5.3 Integra Life Sciences Hemostatic and Tissue Sealing Agents Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Integra Life Sciences Hemostatic and Tissue Sealing Agents Product Portfolio
6.5.5 Integra Life Sciences Recent Developments/Updates
6.6 Advance Medical Solution
6.6.1 Advance Medical Solution Company Information
6.6.2 Advance Medical Solution Description and Business Overview
6.6.3 Advance Medical Solution Hemostatic and Tissue Sealing Agents Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Advance Medical Solution Hemostatic and Tissue Sealing Agents Product Portfolio
6.6.5 Advance Medical Solution Recent Developments/Updates
6.7 CSL Behring
6.7.1 CSL Behring Company Information
6.7.2 CSL Behring Description and Business Overview
6.7.3 CSL Behring Hemostatic and Tissue Sealing Agents Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 CSL Behring Hemostatic and Tissue Sealing Agents Product Portfolio
6.7.5 CSL Behring Recent Developments/Updates
6.8 CryoLife
6.8.1 CryoLife Company Information
6.8.2 CryoLife Description and Business Overview
6.8.3 CryoLife Hemostatic and Tissue Sealing Agents Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 CryoLife Hemostatic and Tissue Sealing Agents Product Portfolio
6.8.5 CryoLife Recent Developments/Updates
6.9 Zimmer Biomet
6.9.1 Zimmer Biomet Company Information
6.9.2 Zimmer Biomet Description and Business Overview
6.9.3 Zimmer Biomet Hemostatic and Tissue Sealing Agents Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Zimmer Biomet Hemostatic and Tissue Sealing Agents Product Portfolio
6.9.5 Zimmer Biomet Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Company Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer Hemostatic and Tissue Sealing Agents Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Pfizer Hemostatic and Tissue Sealing Agents Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
6.11 Medtronic
6.11.1 Medtronic Company Information
6.11.2 Medtronic Description and Business Overview
6.11.3 Medtronic Hemostatic and Tissue Sealing Agents Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Medtronic Hemostatic and Tissue Sealing Agents Product Portfolio
6.11.5 Medtronic Recent Developments/Updates
6.12 Smith & Nephew
6.12.1 Smith & Nephew Company Information
6.12.2 Smith & Nephew Description and Business Overview
6.12.3 Smith & Nephew Hemostatic and Tissue Sealing Agents Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Smith & Nephew Hemostatic and Tissue Sealing Agents Product Portfolio
6.12.5 Smith & Nephew Recent Developments/Updates
6.13 Cohera Medical
6.13.1 Cohera Medical Company Information
6.13.2 Cohera Medical Description and Business Overview
6.13.3 Cohera Medical Hemostatic and Tissue Sealing Agents Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Cohera Medical Hemostatic and Tissue Sealing Agents Product Portfolio
6.13.5 Cohera Medical Recent Developments/Updates
6.14 Shanghai Haohai Biological Technology Co. Ltd.
6.14.1 Shanghai Haohai Biological Technology Co. Ltd. Company Information
6.14.2 Shanghai Haohai Biological Technology Co. Ltd. Description and Business Overview
6.14.3 Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Product Portfolio
6.14.5 Shanghai Haohai Biological Technology Co. Ltd. Recent Developments/Updates
6.15 Shandong Saikesaisi Biotechnology Co., Ltd
6.15.1 Shandong Saikesaisi Biotechnology Co., Ltd Company Information
6.15.2 Shandong Saikesaisi Biotechnology Co., Ltd Description and Business Overview
6.15.3 Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Product Portfolio
6.15.5 Shandong Saikesaisi Biotechnology Co., Ltd Recent Developments/Updates
6.16 Chang ShaHai Run biological technology Co, LTD
6.16.1 Chang ShaHai Run biological technology Co, LTD Company Information
6.16.2 Chang ShaHai Run biological technology Co, LTD Description and Business Overview
6.16.3 Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Product Portfolio
6.16.5 Chang ShaHai Run biological technology Co, LTD Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemostatic and Tissue Sealing Agents Industry Chain Analysis
7.2 Hemostatic and Tissue Sealing Agents Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemostatic and Tissue Sealing Agents Production Mode & Process Analysis
7.4 Hemostatic and Tissue Sealing Agents Sales and Marketing
7.4.1 Hemostatic and Tissue Sealing Agents Sales Channels
7.4.2 Hemostatic and Tissue Sealing Agents Distributors
7.5 Hemostatic and Tissue Sealing Agents Customer Analysis
8 Hemostatic and Tissue Sealing Agents Market Dynamics
8.1 Hemostatic and Tissue Sealing Agents Industry Trends
8.2 Hemostatic and Tissue Sealing Agents Market Drivers
8.3 Hemostatic and Tissue Sealing Agents Market Challenges
8.4 Hemostatic and Tissue Sealing Agents Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Hemostatic and Tissue Sealing Agents Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Hemostatic and Tissue Sealing Agents Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Hemostatic and Tissue Sealing Agents Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Hemostatic and Tissue Sealing Agents Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Hemostatic and Tissue Sealing Agents Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Hemostatic and Tissue Sealing Agents Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Hemostatic and Tissue Sealing Agents Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Hemostatic and Tissue Sealing Agents, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Hemostatic and Tissue Sealing Agents, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Hemostatic and Tissue Sealing Agents, Product Types and Applications
 Table 12. Global Key Manufacturers of Hemostatic and Tissue Sealing Agents, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hemostatic and Tissue Sealing Agents Companies by Tier (Tier 1, Tier 2, Tier 3), based on Hemostatic and Tissue Sealing Agents Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hemostatic and Tissue Sealing Agents Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Hemostatic and Tissue Sealing Agents Sales by Region (K Units), 2021–2026
 Table 18. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Region (2021–2026)
 Table 19. Global Hemostatic and Tissue Sealing Agents Sales by Region (K Units), 2027–2032
 Table 20. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Region (2027–2032)
 Table 21. Global Hemostatic and Tissue Sealing Agents Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Region (2021–2026)
 Table 23. Global Hemostatic and Tissue Sealing Agents Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Region (2027–2032)
 Table 25. North America Hemostatic and Tissue Sealing Agents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Hemostatic and Tissue Sealing Agents Sales by Country (K Units), 2021–2026
 Table 27. North America Hemostatic and Tissue Sealing Agents Sales by Country (K Units), 2027–2032
 Table 28. North America Hemostatic and Tissue Sealing Agents Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Hemostatic and Tissue Sealing Agents Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Hemostatic and Tissue Sealing Agents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Hemostatic and Tissue Sealing Agents Sales by Country (K Units), 2021–2026
 Table 32. Europe Hemostatic and Tissue Sealing Agents Sales by Country (K Units), 2027–2032
 Table 33. Europe Hemostatic and Tissue Sealing Agents Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Hemostatic and Tissue Sealing Agents Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Hemostatic and Tissue Sealing Agents Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Hemostatic and Tissue Sealing Agents Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Hemostatic and Tissue Sealing Agents Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Hemostatic and Tissue Sealing Agents Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Hemostatic and Tissue Sealing Agents Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Hemostatic and Tissue Sealing Agents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Hemostatic and Tissue Sealing Agents Sales by Country (K Units), 2021–2026
 Table 42. Latin America Hemostatic and Tissue Sealing Agents Sales by Country (K Units), 2027–2032
 Table 43. Latin America Hemostatic and Tissue Sealing Agents Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Hemostatic and Tissue Sealing Agents Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Hemostatic and Tissue Sealing Agents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Hemostatic and Tissue Sealing Agents Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Hemostatic and Tissue Sealing Agents Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Hemostatic and Tissue Sealing Agents Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Hemostatic and Tissue Sealing Agents Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Hemostatic and Tissue Sealing Agents Sales (K Units) by Type (2021–2026)
 Table 51. Global Hemostatic and Tissue Sealing Agents Sales (K Units) by Type (2027–2032)
 Table 52. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Type (2021–2026)
 Table 53. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Type (2027–2032)
 Table 54. Global Hemostatic and Tissue Sealing Agents Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Hemostatic and Tissue Sealing Agents Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Type (2021–2026)
 Table 57. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Type (2027–2032)
 Table 58. Global Hemostatic and Tissue Sealing Agents Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Hemostatic and Tissue Sealing Agents Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Hemostatic and Tissue Sealing Agents Sales (K Units) by Application (2021–2026)
 Table 61. Global Hemostatic and Tissue Sealing Agents Sales (K Units) by Application (2027–2032)
 Table 62. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Application (2021–2026)
 Table 63. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Application (2027–2032)
 Table 64. Global Hemostatic and Tissue Sealing Agents Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Hemostatic and Tissue Sealing Agents Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Application (2021–2026)
 Table 67. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Application (2027–2032)
 Table 68. Global Hemostatic and Tissue Sealing Agents Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Hemostatic and Tissue Sealing Agents Price (US$/Unit) by Application (2027–2032)
 Table 70. J&J Company Information
 Table 71. J&J Description and Business Overview
 Table 72. J&J Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. J&J Hemostatic and Tissue Sealing Agents Product
 Table 74. J&J Recent Developments/Updates
 Table 75. Baxter Company Information
 Table 76. Baxter Description and Business Overview
 Table 77. Baxter Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Baxter Hemostatic and Tissue Sealing Agents Product
 Table 79. Baxter Recent Developments/Updates
 Table 80. C R Bard Company Information
 Table 81. C R Bard Description and Business Overview
 Table 82. C R Bard Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. C R Bard Hemostatic and Tissue Sealing Agents Product
 Table 84. C R Bard Recent Developments/Updates
 Table 85. B Braun Company Information
 Table 86. B Braun Description and Business Overview
 Table 87. B Braun Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. B Braun Hemostatic and Tissue Sealing Agents Product
 Table 89. B Braun Recent Developments/Updates
 Table 90. Integra Life Sciences Company Information
 Table 91. Integra Life Sciences Description and Business Overview
 Table 92. Integra Life Sciences Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Integra Life Sciences Hemostatic and Tissue Sealing Agents Product
 Table 94. Integra Life Sciences Recent Developments/Updates
 Table 95. Advance Medical Solution Company Information
 Table 96. Advance Medical Solution Description and Business Overview
 Table 97. Advance Medical Solution Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Advance Medical Solution Hemostatic and Tissue Sealing Agents Product
 Table 99. Advance Medical Solution Recent Developments/Updates
 Table 100. CSL Behring Company Information
 Table 101. CSL Behring Description and Business Overview
 Table 102. CSL Behring Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. CSL Behring Hemostatic and Tissue Sealing Agents Product
 Table 104. CSL Behring Recent Developments/Updates
 Table 105. CryoLife Company Information
 Table 106. CryoLife Description and Business Overview
 Table 107. CryoLife Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. CryoLife Hemostatic and Tissue Sealing Agents Product
 Table 109. CryoLife Recent Developments/Updates
 Table 110. Zimmer Biomet Company Information
 Table 111. Zimmer Biomet Description and Business Overview
 Table 112. Zimmer Biomet Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Zimmer Biomet Hemostatic and Tissue Sealing Agents Product
 Table 114. Zimmer Biomet Recent Developments/Updates
 Table 115. Pfizer Company Information
 Table 116. Pfizer Description and Business Overview
 Table 117. Pfizer Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Pfizer Hemostatic and Tissue Sealing Agents Product
 Table 119. Pfizer Recent Developments/Updates
 Table 120. Medtronic Company Information
 Table 121. Medtronic Description and Business Overview
 Table 122. Medtronic Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Medtronic Hemostatic and Tissue Sealing Agents Product
 Table 124. Medtronic Recent Developments/Updates
 Table 125. Smith & Nephew Company Information
 Table 126. Smith & Nephew Description and Business Overview
 Table 127. Smith & Nephew Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Smith & Nephew Hemostatic and Tissue Sealing Agents Product
 Table 129. Smith & Nephew Recent Developments/Updates
 Table 130. Cohera Medical Company Information
 Table 131. Cohera Medical Description and Business Overview
 Table 132. Cohera Medical Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Cohera Medical Hemostatic and Tissue Sealing Agents Product
 Table 134. Cohera Medical Recent Developments/Updates
 Table 135. Shanghai Haohai Biological Technology Co. Ltd. Company Information
 Table 136. Shanghai Haohai Biological Technology Co. Ltd. Description and Business Overview
 Table 137. Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Product
 Table 139. Shanghai Haohai Biological Technology Co. Ltd. Recent Developments/Updates
 Table 140. Shandong Saikesaisi Biotechnology Co., Ltd Company Information
 Table 141. Shandong Saikesaisi Biotechnology Co., Ltd Description and Business Overview
 Table 142. Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Product
 Table 144. Shandong Saikesaisi Biotechnology Co., Ltd Recent Developments/Updates
 Table 145. Chang ShaHai Run biological technology Co, LTD Company Information
 Table 146. Chang ShaHai Run biological technology Co, LTD Description and Business Overview
 Table 147. Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Product
 Table 149. Chang ShaHai Run biological technology Co, LTD Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Hemostatic and Tissue Sealing Agents Distributors List
 Table 153. Hemostatic and Tissue Sealing Agents Customers List
 Table 154. Hemostatic and Tissue Sealing Agents Market Trends
 Table 155. Hemostatic and Tissue Sealing Agents Market Drivers
 Table 156. Hemostatic and Tissue Sealing Agents Market Challenges
 Table 157. Hemostatic and Tissue Sealing Agents Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hemostatic and Tissue Sealing Agents
 Figure 2. Global Hemostatic and Tissue Sealing Agents Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Hemostatic and Tissue Sealing Agents Market Share by Type: 2025 & 2032
 Figure 4. Hemostatic Product Picture
 Figure 5. Sealant Gum Product Picture
 Figure 6. Global Hemostatic and Tissue Sealing Agents Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Hemostatic and Tissue Sealing Agents Market Share by Application: 2025 & 2032
 Figure 8. Minimally Invasive Surgery
 Figure 9. General Surgery
 Figure 10. Other
 Figure 11. Global Hemostatic and Tissue Sealing Agents Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Hemostatic and Tissue Sealing Agents Market Size (US$ Million), 2021–2032
 Figure 13. Global Hemostatic and Tissue Sealing Agents Sales (K Units), 2021–2032
 Figure 14. Global Hemostatic and Tissue Sealing Agents Average Price (US$/Unit), 2021–2032
 Figure 15. Hemostatic and Tissue Sealing Agents Report Years Considered
 Figure 16. Hemostatic and Tissue Sealing Agents Sales Share by Manufacturers in 2025
 Figure 17. Global Hemostatic and Tissue Sealing Agents Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Hemostatic and Tissue Sealing Agents Players: Market Share by Revenue in Hemostatic and Tissue Sealing Agents in 2025
 Figure 19. Hemostatic and Tissue Sealing Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Hemostatic and Tissue Sealing Agents Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2021–2032)
 Figure 22. North America Hemostatic and Tissue Sealing Agents Revenue Market Share by Country (2021–2032)
 Figure 23. U.S. Hemostatic and Tissue Sealing Agents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Hemostatic and Tissue Sealing Agents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2021–2032)
 Figure 26. Europe Hemostatic and Tissue Sealing Agents Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Hemostatic and Tissue Sealing Agents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Hemostatic and Tissue Sealing Agents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Hemostatic and Tissue Sealing Agents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Hemostatic and Tissue Sealing Agents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Hemostatic and Tissue Sealing Agents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Hemostatic and Tissue Sealing Agents Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Hemostatic and Tissue Sealing Agents Revenue Market Share by Region (2021–2032)
 Figure 34. China Hemostatic and Tissue Sealing Agents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Hemostatic and Tissue Sealing Agents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Hemostatic and Tissue Sealing Agents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Hemostatic and Tissue Sealing Agents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Hemostatic and Tissue Sealing Agents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Hemostatic and Tissue Sealing Agents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Indonesia Hemostatic and Tissue Sealing Agents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Thailand Hemostatic and Tissue Sealing Agents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Malaysia Hemostatic and Tissue Sealing Agents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Hemostatic and Tissue Sealing Agents Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Hemostatic and Tissue Sealing Agents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Hemostatic and Tissue Sealing Agents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Hemostatic and Tissue Sealing Agents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Hemostatic and Tissue Sealing Agents Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Hemostatic and Tissue Sealing Agents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Hemostatic and Tissue Sealing Agents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Hemostatic and Tissue Sealing Agents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Hemostatic and Tissue Sealing Agents by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Hemostatic and Tissue Sealing Agents by Type (2021–2032)
 Figure 55. Global Hemostatic and Tissue Sealing Agents Price (US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Hemostatic and Tissue Sealing Agents by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Hemostatic and Tissue Sealing Agents by Application (2021–2032)
 Figure 58. Global Hemostatic and Tissue Sealing Agents Price (US$/Unit) by Application (2021–2032)
 Figure 59. Hemostatic and Tissue Sealing Agents Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS